Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
13.19
+0.44 (3.45%)
Feb 20, 2026, 4:00 PM EST - Market closed
Biodesix Employees
Biodesix had 273 employees as of December 31, 2024. The number of employees increased by 56 or 25.81% compared to the previous year.
Employees
273
Change (1Y)
56
Growth (1Y)
25.81%
Revenue / Employee
$293,674
Profits / Employee
-$144,821
Market Cap
104.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | 200 | - | - |
| Sep 30, 2020 | 186 | - | - |
| Jun 30, 2020 | 154 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| Fulgent Genetics | 1,313 |
| Castle Biosciences | 823 |
| Burning Rock Biotech | 674 |
| FONAR | 535 |
| MDxHealth | 312 |
| Prenetics Global | 285 |
| Personalis | 229 |
BDSX News
- 9 days ago - Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 5 weeks ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) - GlobeNewsWire
- 2 months ago - Biodesix to Present New Data at Two Major Upcoming Scientific Meetings - GlobeNewsWire
- 3 months ago - Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Biodesix Announces Third Quarter 2025 Results and Highlights - GlobeNewsWire
- 4 months ago - Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - GlobeNewsWire
- 4 months ago - Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays - GlobeNewsWire
- 4 months ago - Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire